iCAD, Inc., a US-based company, is dedicated to providing cancer detection and therapy solutions to its customers. The company operates through two segments, namely, Cancer Detection and Cancer Therapy. Its breast AI suite, which consists of cancer detection, automated density assessment, and breast cancer risk assessment solutions, offers benefits for both 2D and 3D mammography. The company offers several products, including PowerLook, SecondLook, PowerLook Density Assessment, ProFound AI, ProFound AI Risk, and VeraLook. Its Xoft Axxent electronic brachytherapy systems are used for the treatment of early-stage breast, non-melanoma skin, and gynecological cancers in various medical settings. The company operates through direct sales organizations, as well as via original equipment manufacturer partners, distributors, technology platform partners, and resellers. The company was originally known as Howtek, Inc. but changed its name to iCAD, Inc. in June 2002. It was incorporated in 1984 and is headquartered in Nashua, New Hampshire. The company exports its products to Europe, Taiwan, Canada, China, and other international destinations.